Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients hematologic disorders, cancer and rare immune diseases.
View Top Employees from Rigel Pharmaceuticals Inc.Website | http://www.rigel.com |
Ticker | RIGL |
Revenue | $44 million |
Funding | $888.4 million |
Employees | 261 (237 on RocketReach) |
Founded | 1996 |
Address | 1180 Veterans Blvd, South San Francisco, California 94080, US |
Phone | (650) 624-1100 |
Fax | (650) 624-1101 |
Technologies |
JavaScript,
HTML,
PHP
+45 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Pharmaceutical, Health Care, Therapeutics |
Keywords | Oncology, Small Molecule Drug Discovery, Cancer Drugs, Rare Disease, Autoimmune Disease, Inflammatory Diseases |
Competitors | Concert Pharmaceuticals, Inc., Corbus Pharmaceuticals, Crystax Pharmaceuticals / Oryzon Genomics, GlycoMimetics, PTC Therapeutics, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Rigel Pharmaceuticals Inc. employee's phone or email?
The Rigel Pharmaceuticals Inc. annual revenue was $44 million in 2024.
Esteban Masuda is the Executive Vice President and Head of Research at Rigel Pharmaceuticals Inc. of Rigel Pharmaceuticals Inc..
237 people are employed at Rigel Pharmaceuticals Inc..
Rigel Pharmaceuticals Inc. is based in South San Francisco, California.
The NAICS codes for Rigel Pharmaceuticals Inc. are [325, 32, 32541, 3254].
The SIC codes for Rigel Pharmaceuticals Inc. are [283, 28].